JPRN-jRCT2080221357未知3 期
A double blind study of KRN125 compared to KRN8601 for chemotherapy-induced neutropenia in malignant lymphoma
Kyowa Hakko Kirin Co., Ltd.0 个研究点开始时间: 2011年1月21日最近更新:
试验速览
- 阶段
- 3 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Diagnosed with Hodgkin's or non-Hodgkin's lymphoma
- •- Going to receive CHASE treatment regimen
- •- ECOG PS =< 2
- •- Appropriate bone marrow, hepatic and renal functions
- •- Written informed consent
排除标准
- •- Double cancer
- •- Previous bone marrow or peripheral blood stem cell transplantation
- •- More than 3 prior chemotherapies for salvage treatment regimen
- •- Primary hematologic disease such as myelodysplastic syndrome or aplastic anemia
- •- Undergoing interstitial pneumonia treatment
- •- Previous radiotherapy within 4 weeks of enrollment
研究者
相似试验
未知
3 期
A phase III, clinical study of KRN125JPRN-jRCT2080221502Kyowa Hakko Kirin Co., Ltd.
未知
3 期
A phase III, double blind, comparative study of KRN125Chemotherapy-induced neutropeniaJPRN-jRCT2080221407Kyowa Hakko Kirin Co., Ltd.
未知
2 期
A dose finding study of KRN125Chemotherapy-induced neutropeniaJPRN-jRCT2080220922Kyowa Hakko Kirin Co., Ltd.
尚未招募
3 期
To compare clinical performance of Cention-N and Ketac Uinversal for class 2 restorations in primary molars-A split mouth study.CTRI/2021/02/030984SGT UNIVERSITY
尚未招募
1 期
A OPEN LABEL CLINICAL COMPARATIVE STUDY OF KARVEER TAIL AND KARVEER CREAM ON KIKKISA WITH SPECIAL REFERENCE TO STRIAE GRAVIDARUMCTRI/2022/05/042417SANEGURUJI AROGYA KENDRA